Shanghai Hile Bio-tech Net Asset Quality Index
Shanghai Hile Bio-tech net asset quality index. Shanghai Hile Bio-tech (603718) has a Net Asset Quality Index of 70.4% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥1.38 Billion minus total liabilities of CN¥408.00 Million yields net assets of CN¥971.57 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Shanghai Hile Bio-tech book value and equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Shanghai Hile Bio-tech (2011–2025)
Net asset quality index of Shanghai Hile Bio-tech from 2011 to 2025. This chart shows how Shanghai Hile Bio-tech's Net Asset Quality Index has evolved across 15 annual periods from 2011 to 2025. As of June 2026, the index stands at 70.4%, representing net assets of CN¥971.57 Million against total assets of CN¥1.38 Billion CNY. Check Shanghai Hile Bio-tech strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Shanghai Hile Bio-tech Net Asset Quality Index by Year (2011–2025)
Shanghai Hile Bio-tech net asset quality index by year from 2011 to 2025. The table below presents the year-by-year Net Asset Quality Index for Shanghai Hile Bio-tech from 2011 to 2025, covering 15 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 603718 market cap.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 79.6% | CN¥895.97 Million | CN¥1.13 Billion | CN¥229.14 Million | ▼ -13.6 pp |
| 2024 | 93.2% | CN¥1.70 Billion | CN¥1.83 Billion | CN¥123.65 Million | ▲ +22.4 pp |
| 2023 | 70.9% | CN¥1.17 Billion | CN¥1.66 Billion | CN¥482.96 Million | ▼ -2.5 pp |
| 2022 | 73.4% | CN¥1.11 Billion | CN¥1.51 Billion | CN¥403.25 Million | ▲ +19.8 pp |
| 2021 | 53.5% | CN¥987.19 Million | CN¥1.84 Billion | CN¥856.90 Million | ▼ -0.3 pp |
| 2020 | 53.9% | CN¥962.20 Million | CN¥1.79 Billion | CN¥824.54 Million | ▼ -4.5 pp |
| 2019 | 58.3% | CN¥992.57 Million | CN¥1.70 Billion | CN¥708.72 Million | ▼ -0.3 pp |
| 2018 | 58.7% | CN¥1.03 Billion | CN¥1.75 Billion | CN¥722.81 Million | ▼ -8.4 pp |
| 2017 | 67.1% | CN¥1.07 Billion | CN¥1.60 Billion | CN¥526.83 Million | ▼ -0.8 pp |
| 2016 | 67.9% | CN¥1.01 Billion | CN¥1.48 Billion | CN¥474.55 Million | ▼ -9.7 pp |
| 2015 | 77.7% | CN¥963.31 Million | CN¥1.24 Billion | CN¥277.01 Million | ▼ -7.7 pp |
| 2014 | 85.3% | CN¥558.50 Million | CN¥654.48 Million | CN¥95.98 Million | ▲ +2.0 pp |
| 2013 | 83.3% | CN¥500.66 Million | CN¥600.84 Million | CN¥100.17 Million | ▼ -0.1 pp |
| 2012 | 83.5% | CN¥467.89 Million | CN¥560.66 Million | CN¥92.78 Million | ▲ +3.0 pp |
| 2011 | 80.5% | CN¥405.74 Million | CN¥504.03 Million | CN¥98.29 Million | — |